An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials. (April 2017) - Conaghan, P.; Strand, V.; Hunter, D.; Kraus, V.B.; Berenbaum, F.; Katz, N.P.; Lufkin, J.; Johnson, J.R.; Kelley, S.; Bodick, N.